Clinical Trials Browser

Phase 2 × dostarlimab × Other solid neoplasm × Clear all

NCT07013851 2025-06-10

NADIA

Phase 2 Not yet recruiting

GynecologicOther solid neoplasm

MMRd/MSI-H Stage II-III Endometrial Cancer

NCT06365970 2025-02-03

Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers

Phase 2 Withdrawn

GastrointestinalOther solid neoplasm

MMR-D/MSI-H Colorectal Cancers

NCT04940637 2023-05-12

UNITO-001

Phase 2 Unknown

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant